相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pharmacokinetics and tissue distribution of Kendine 91, a novel histone deacetylase inhibitor, in mice
Dorleta Otaegui et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Development of the pan-DAC inhibitor panobinostat (LBH589): Successes and challenges
Peter Atadja
CANCER LETTERS (2009)
Survival motor neuron gene 2 silencing by DNA methylation correlates with spinal muscular atrophy disease severity and can be bypassed by histone deacetylase inhibition
Jan Hauke et al.
HUMAN MOLECULAR GENETICS (2009)
Regulation of SMN Protein Stability
Barrington G. Burnett et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Phase II Open Label Study of Valproic Acid in Spinal Muscular Atrophy
Kathryn J. Swoboda et al.
PLOS ONE (2009)
5-(N-ethyl-N-isopropyl)-amiloride enhances SMN2 Exon 7 inclusion and protein expression in spinal muscular atrophy cells
Chung-Yee Yuo et al.
ANNALS OF NEUROLOGY (2008)
SMN deficiency causes tissue-specific perturbations in the repertoire of snRNAs and widespread defects in splicing
Zhenxi Zhang et al.
CELL (2008)
Histone deacetylase inhibitor panobinostat induces clinical responses with associated alterations in gene expression profiles in cutaneous T-cell lymphoma
Leigh Ellis et al.
CLINICAL CANCER RESEARCH (2008)
Messenger RNA regulation: to translate or to degrade
Ann-Bin Shyu et al.
EMBO JOURNAL (2008)
Histone deacetylase inhibitors:: possible implications for neurodegenerative disorders
Eric Hahnen et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
Reduced SMN protein impairs maturation of the neuromuscular junctions in mouse models of spinal muscular atrophy
Shingo Kariya et al.
HUMAN MOLECULAR GENETICS (2008)
TDP-43 Overexpression Enhances Exon 7 Inclusion during the Survival of Motor Neuron Pre-mRNA Splicing
Jayarama Krishnan Bose et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Multiple therapeutic effects of valproic acid in spinal muscular atrophy model mice
Li-Kai Tsai et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2008)
Ubiquitin, the proteasome and protein degradation in neuronal function and dysfunction
Hwan-Ching Tai et al.
NATURE REVIEWS NEUROSCIENCE (2008)
Plastin 3 is a protective modifier of autosomal recessive spinal muscular atrophy
Gabriela E. Oprea et al.
SCIENCE (2008)
Selective vulnerability of motor neurons and dissociation of pre- and post-synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy
Lyndsay M. Murray et al.
HUMAN MOLECULAR GENETICS (2008)
Histone deacetylase inhibitors regulate retinoic acid receptor β expression in neuroblastoma cells by both transcriptional and posttranscriptional mechanisms
Maxy De los Santos et al.
MOLECULAR ENDOCRINOLOGY (2007)
SMN transcript stability: Could modulation of messenger RNA degradation provide a novel therapy for spinal muscular atrophy?
Christopher R. Heier et al.
JOURNAL OF CHILD NEUROLOGY (2007)
Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy
Amy M. Avila et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
An intronic element contributes to splicing repression in spinal muscular atrophy
Tsuyoshi Kashima et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Valproate may improve strength and function in patients with type III/IV spinal muscle atrophy
Conrad C. Weihl et al.
NEUROLOGY (2006)
The benzamide M344, a novel histone deacetylase inhibitor, significantly increases SMN2 RNA/protein levels in spinal muscular atrophy cells
Markus Riessland et al.
HUMAN GENETICS (2006)
In vitro and ex vivo evaluation of second-generation histone deacetylase inhibitors for the treatment of spinal muscular atrophy
E Hahnen et al.
JOURNAL OF NEUROCHEMISTRY (2006)
In vivo activation of SMN in spinal muscular atrophy carriers and patients treated with valproate
Lars Brichta et al.
ANNALS OF NEUROLOGY (2006)
Mildly affected patients with spinal muscular atrophy are partially protected by an increased SMN2 copy number
B Wirth et al.
HUMAN GENETICS (2006)
Determinants of exon 7 splicing in the spinal muscular atrophy genes, SMN1 and SMN2
L Cartegni et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
Diverse small-molecule modulators of SMN expression found by high-throughput compound screening: early leads towards a therapeutic for spinal muscular atrophy
J Jarecki et al.
HUMAN MOLECULAR GENETICS (2005)
The role of histone acetylation in SMN gene expression
LE Kernochan et al.
HUMAN MOLECULAR GENETICS (2005)
Active chromatin domains are defined by acetylation islands revealed by genome-wide mapping
TY Roh et al.
GENES & DEVELOPMENT (2005)
Phenylbutyrate increases SMN gene expression in spinal muscular atrophy patients
C Brahe et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2005)
Degradation of survival motor neuron (SMN) protein is mediated via the ubiquitin/proteasome pathway
HC Chang et al.
NEUROCHEMISTRY INTERNATIONAL (2004)
Phenylbutyrate increases SMN expression in vitro: relevance for treatment of spinal muscular atrophy
C Andreassi et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2004)
Smn, the spinal muscular atrophy-determining gene product, modulates axon growth and localization of β-actin mRNA in growth cones of motoneurons
W Rossoll et al.
JOURNAL OF CELL BIOLOGY (2003)
Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy
L Brichta et al.
HUMAN MOLECULAR GENETICS (2003)
Knockdown of the survival motor neuron (Smn) protein in zebrafish causes defects in motor axon outgrowth and pathfinding
ML McWhorter et al.
JOURNAL OF CELL BIOLOGY (2003)
A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy
T Kashima et al.
NATURE GENETICS (2003)
Valproic acid increases SMN levels in spinal muscular atrophy patient cells
CJ Sumner et al.
ANNALS OF NEUROLOGY (2003)
SMN-mediated assembly of RNPs: a complex story
G Meister et al.
TRENDS IN CELL BIOLOGY (2002)
hnRNP-G promotes exon 7 inclusion of survival motor neuron (SMN) via direct interaction with Htra2-β1
Y Hofmann et al.
HUMAN MOLECULAR GENETICS (2002)
Survival motor neuron (SMN) protein: role in neurite outgrowth and neuromuscular maturation during neuronal differentiation and development
L Fan et al.
HUMAN MOLECULAR GENETICS (2002)
Spinal muscular atrophy: state-of-the-art and therapeutic perspectives
B Wirth
AMYOTROPHIC LATERAL SCLEROSIS (2002)
Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1
L Cartegni et al.
NATURE GENETICS (2002)
Quantitative analyses of SMN1 and SMN2 based on real-time LightCycler PCR:: Fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy
M Feldkötter et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2002)
SRp30c-dependent stimulation of survival motor neuron (SMN) exon 7 inclusion is facilitated by a direct interaction with hTra2 beta 1
PJ Young et al.
HUMAN MOLECULAR GENETICS (2002)
Treatment of spinal muscular atrophy by sodium butyrate
JG Chang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Htra2-β1 stimulates an exonic splicing enhancer and can restore full-length SMN expression to survival motor neuron 2 (SMN2)
Y Hofmann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN
CL Lorson et al.
HUMAN MOLECULAR GENETICS (2000)
A mouse model for spinal muscular atrophy
HM Hsieh-Li et al.
NATURE GENETICS (2000)
分享论文
